NCT04507139View on ClinicalTrials.gov

Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 10, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Parkinson Disease
Trial Locations (3)

19107

University of Pennsylvania, Philadelphia

06510

Institute For Neurodegenerative Disorders, New Haven

02118

Boston University Medical Center, Boston

All Listed Sponsors
lead

Michael J. Fox Foundation for Parkinson's Research

OTHER